Trade Summary

2 days ago, Mahony Susan, serving as Dir at Axsome Therapeutics, Inc. (AXSM), sold 600 shares at $241.70 per share, for a total transaction value of $145,017.00. Following this transaction, Mahony Susan now holds 829 shares of AXSM.

This sale represents a 41.99% decrease in Mahony Susan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 (accepted Jun 10, 9:49 PM ET), 2 days after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.